These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8852407)

  • 1. Induction of anti-malarial transmission blocking immunity with a recombinant ookinete surface antigen of Plasmodium berghei produced in silkworm larvae using the baculovirus expression vector system.
    Matsuoka H; Kobayashi J; Barker GC; Miura K; Chinzei Y; Miyajima S; Ishii A; Sinden RE
    Vaccine; 1996 Feb; 14(2):120-6. PubMed ID: 8852407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the Plasmodium berghei ookinete protein Pbs21 in a baculovirus-insect cell system produces an efficient transmission blocking immunogen.
    Margos G; Kurtenbach K; Posnett E; Barker GC; Matsuoka H; Paton MG; Sinden RE
    Parasite Immunol; 1995 Apr; 17(4):167-76. PubMed ID: 7624157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of the glycosylphosphatidylinositol anchor on the production and immunogenicity of recombinant ookinete surface antigen Pbs21 of Plasmodium berghei when prepared in a baculovirus expression system.
    Martínez AP; Margos G; Barker G; Sinden RE
    Parasite Immunol; 2000 Oct; 22(10):493-500. PubMed ID: 11012975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the immunogenicity of a recombinant ookinete surface antigen Pbs21 from Plasmodium berghei expressed in Escherichia coli.
    Matsuoka H; Paton MG; Barker GC; Alejo Blanco AR; Sinden RE
    Parasite Immunol; 1994 Jan; 16(1):27-34. PubMed ID: 8152832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate.
    Zheng W; Liu F; He Y; Liu Q; Humphreys GB; Tsuboi T; Fan Q; Luo E; Cao Y; Cui L
    Parasit Vectors; 2017 Jan; 10(1):8. PubMed ID: 28057055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro.
    Sala KA; Nishiura H; Upton LM; Zakutansky SE; Delves MJ; Iyori M; Mizutani M; Sinden RE; Yoshida S; Blagborough AM
    Vaccine; 2015 Jan; 33(3):437-45. PubMed ID: 25454088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope mapping on the ookinete surface antigen Pbs21 of Plasmodium berghei: identification of the site of binding of transmission-blocking monoclonal antibody 13.1.
    Spano F; Matsuoka H; Ozawa R; Chinzei Y; Sinden RE
    Parassitologia; 1996 Dec; 38(3):559-63. PubMed ID: 9257345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium berghei.
    Zheng W; Kou X; Du Y; Liu F; Yu C; Tsuboi T; Fan Q; Luo E; Cao Y; Cui L
    Vaccine; 2016 May; 34(23):2570-8. PubMed ID: 27083421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immunity induced by the affinity-purified 21-kilodalton zygote-ookinete surface antigen of Plasmodium berghei.
    Tirawanchai N; Winger LA; Nicholas J; Sinden RE
    Infect Immun; 1991 Jan; 59(1):36-44. PubMed ID: 1987051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-chain antibody fragment specific for the Plasmodium berghei ookinete protein Pbs21 confers transmission blockade in the mosquito midgut.
    Yoshida S; Matsuoka H; Luo E; Iwai K; Arai M; Sinden RE; Ishii A
    Mol Biochem Parasitol; 1999 Nov; 104(2):195-204. PubMed ID: 10593175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic expression of a mosquito-stage malarial protein, Pbs21, in blood stages of transformed Plasmodium berghei and induction of an immune response upon infection.
    Margos G; van Dijk MR; Ramesar J; Janse CJ; Waters AP; Sinden RE
    Infect Immun; 1998 Aug; 66(8):3884-91. PubMed ID: 9673276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the modes of action of anti-Pbs21 malaria transmission-blocking immunity: ookinete to oocyst differentiation in vivo.
    Ranawaka GR; Fleck SL; Blanco AR; Sinden RE
    Parasitology; 1994 Nov; 109 ( Pt 4)():403-11. PubMed ID: 7800408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine.
    Kou X; Zheng W; Du F; Liu F; Wang M; Fan Q; Cui L; Luo E; Cao Y
    Parasit Vectors; 2016 Apr; 9():190. PubMed ID: 27038925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential.
    Liu F; Li L; Zheng W; He Y; Wang Y; Zhu X; Tsuboi T; Cui L; Wang M; Cao Y
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and transmission-blocking potential of quiescin sulfhydryl oxidase in
    Zheng W; Cheng S; Liu F; Yu X; Zhao Y; Yang F; Thongpoon S; Roobsoong W; Sattabongkot J; Luo E; Cui L; Cao Y
    Front Cell Infect Microbiol; 2024; 14():1451063. PubMed ID: 39258252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conserved malaria parasite antigen Pb22 plays a critical role in male gametogenesis in Plasmodium berghei.
    Liu F; Yang F; Wang Y; Hong M; Zheng W; Min H; Li D; Jin Y; Tsuboi T; Cui L; Cao Y
    Cell Microbiol; 2021 Mar; 23(3):e13294. PubMed ID: 33222390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission.
    Wang J; Zheng W; Liu F; Wang Y; He Y; Zheng L; Fan Q; Luo E; Cao Y; Cui L
    Malar J; 2017 Nov; 16(1):458. PubMed ID: 29132428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of classical swine fever virus envelope glycoprotein E2 as recombinant polyhedra in baculovirus-infected silkworm larvae.
    Lee KS; Sohn MR; Kim BY; Choo YM; Woo SD; Yoo SS; Je YH; Choi JY; Roh JY; Koo HN; Jin BR
    Mol Biotechnol; 2012 Mar; 50(3):211-20. PubMed ID: 21706129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of transmission-blocking potential of PvPSOP25 using transgenic murine malaria parasite and clinical isolates.
    Zhang B; Feng H; Zhao Y; Zhang D; Yu X; Li Y; Zeng Y; Thongpoon S; Roobsoong W; Wu Y; Liu F; Sattabongkot J; Min H; Cui L; Cao Y
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012231. PubMed ID: 38865344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection.
    Yoshida S; Kondoh D; Arai E; Matsuoka H; Seki C; Tanaka T; Okada M; Ishii A
    Virology; 2003 Nov; 316(1):161-70. PubMed ID: 14599800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.